These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32382418)

  • 1. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019.
    Hou H; Wang T; Zhang B; Luo Y; Mao L; Wang F; Wu S; Sun Z
    Clin Transl Immunology; 2020 May; 9(5):e01136. PubMed ID: 32382418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
    Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
    PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China.
    Bai Z; Li Q; Chen Q; Niu C; Wei Y; Huang H; Zhao W; Chen N; Yao X; Zhang Q; Mu C; Feng J; Zhu C; Li Z; Ding M; Feng B; Jin C; Lu X; Yang Y; Wu S; Shu X; Hu L; Qiu H; Huang Y
    J Intensive Med; 2022 Jan; 2(1):32-38. PubMed ID: 36785701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
    Zhang LX; Miao SY; Qin ZH; Wu JP; Chen HY; Sun HB; Xie Y; Du YQ; Shen J
    Mol Diagn Ther; 2020 Oct; 24(5):601-609. PubMed ID: 32710269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
    Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera.
    Ha B; Jadhao S; Hussaini L; Gibson T; Stephens K; Salazar L; Ciric C; Taylor M; Rouphael N; Edupuganti S; Rostad CA; Tompkins SM; Anderson EJ; Anderson LJ
    Microbiol Spectr; 2021 Oct; 9(2):e0045821. PubMed ID: 34494855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).
    Mitani A; Hamada K; Yoshikawa N; Morita Y; Horie T; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Yao A; Shimura T; Kurano M; Yatomi Y; Yanagimoto S
    J Infect Chemother; 2021 Sep; 27(9):1342-1349. PubMed ID: 34158239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
    Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
    J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
    Wu LX; Wang H; Gou D; Fu G; Wang J; Guo BQ
    J Clin Lab Anal; 2021 Jan; 35(1):e23649. PubMed ID: 33184940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients.
    Kaduskar O; Gurav YK; Deshpande K; Desphande GR; Yadav P; Rakhe A; Tilekar BN; Gomade P; Salunke A; Patil C; Dange V; Salve P; Patsute S; Abraham P; Sapkal GN
    Indian J Med Res; 2022; 155(5&6):565-569. PubMed ID: 36124504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors.
    Luo C; Liu M; Li Q; Zheng X; Ai W; Gong F; Fan J; Liu S; Wang X; Luo J
    Int J Infect Dis; 2021 Jul; 108():57-62. PubMed ID: 33932603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.
    Servian CDP; Spadafora-Ferreira M; Dos Anjos DCC; Guilarde AO; Gomes-Junior AR; Borges MASB; Masson LC; Silva JMM; de Lima MHA; Moraes BGN; Souza SM; Xavier LE; de Oliveira DCA; Batalha-Carvalho JV; Moro AM; Bocca AL; Pfrimer IAH; Costa NL; Feres VCR; Fiaccadori FS; Souza M; Gardinassi LG; Durigon EL; Romão PRT; Jorge SAC; Coelho V; Botosso VF; Fonseca SG
    Front Immunol; 2023; 14():1206979. PubMed ID: 37876932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer.
    Cameron A; Bohrhunter JL; Porterfield CA; Mangat R; Karasick MH; Pearson Z; Angeloni S; Pecora ND
    Microbiol Spectr; 2022 Apr; 10(2):e0250721. PubMed ID: 35389244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.
    Padoan A; Cosma C; Sciacovelli L; Faggian D; Plebani M
    Clin Chem Lab Med; 2020 Jun; 58(7):1081-1088. PubMed ID: 32301749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.